Date: 2015-04-13
Type of information: Collaboration agreement
Compound: statistical analyses of large-scale multi-phenotype genetic association data
Company: Eisai (Japan) Genomics (UK)
Therapeutic area: Technology - Services
Type agreement: collaboration
Action mechanism:
Disease:
Details: * On April 13, 2015, Eisai and Genomics announced that they have entered into a collaborative agreement to use Genomics\' statistical analyses of large-scale multi-phenotype genetic association data to inform Eisai\'s drug discovery process, including target selection, target validation, indication selection and repositioning. Genomics, the Oxford based genome analytics company, will be partnering with Eisai\'s new Integrated Human Genomics (IHGx) Research Unit which operates directly under the supervision of Eisai Product Creation Systems\' Chief Clinical Officer. This collaboration will use genomic analysis to accelerate the discovery and development of new drugs.
Financial terms:
Latest news:
